These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 8794679)

  • 1. [Thrombolytic therapy in acute myocardial infarction--update].
    Jaffe R; Gotsman MS; Zahger D
    Harefuah; 1996 Jun; 130(11):751-7. PubMed ID: 8794679
    [No Abstract]   [Full Text] [Related]  

  • 2. Streptokinase versus alteplase in acute myocardial infarction.
    Friedman HS
    J R Soc Med; 1996 Aug; 89(8):427-30. PubMed ID: 8795494
    [No Abstract]   [Full Text] [Related]  

  • 3. [The prevention of reocclusion after thrombolysis in acute myocardial infarct: is tissue-type plasminogen activator really superior to streptokinase?].
    Negrini M
    G Ital Cardiol; 1995 Apr; 25(4):511-5. PubMed ID: 7677921
    [No Abstract]   [Full Text] [Related]  

  • 4. Current status of thrombolytic therapy in acute myocardial infarction.
    Dutta AL; Mandal M
    J Indian Med Assoc; 1991 Nov; 89(11):322-4. PubMed ID: 1787323
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experience with the thrombolytic therapy of myocardial infarct].
    Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA
    Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thrombolytic treatment of acute myocardial infarct. 1].
    Soares-Costa JT; Soares-Costa TJ; Gabriel HM
    Acta Med Port; 1998 May; 11(5):409-19. PubMed ID: 9951051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term effects of thrombolytic therapy in acute myocardial infarction.
    Shah LS
    J Assoc Physicians India; 1994 Jan; 42(1):9-11. PubMed ID: 7836276
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tissue plasminogen activator is the best thrombolytic agent].
    Bates E
    Arq Bras Cardiol; 1994 Jul; 63(1):57-8. PubMed ID: 7857215
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thrombolytic therapy in acute myocardial infarct--is it being used to the fullest?].
    Carôla B; Calçada-Correia L; Pedro PG; Conduto R; Dionísio I; Fiuza M; Dias E; Vaz Carneiro A; Amador MG; de Pádua F; Lopes MG
    Rev Port Cardiol; 1996 Dec; 15(12):867-76, 863. PubMed ID: 9052962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Future developments in thrombolytic therapy].
    Bode C; Runge MS
    Z Kardiol; 1993; 82 Suppl 2():187-90. PubMed ID: 8328201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-dose thrombolytic following myocardial infarction.
    Furniss SS; Millar RN; Commerford PJ
    S Afr Med J; 1997 Feb; 87(2):179, 182. PubMed ID: 9107231
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thrombolytic therapy of acute myocardial infarction].
    Chen JL
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):69-70. PubMed ID: 15808085
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombolytic therapy for acute ischaemic stroke.
    Lane N
    Lancet; 1997 Nov; 350(9089):1475-6; author reply 1477. PubMed ID: 9371187
    [No Abstract]   [Full Text] [Related]  

  • 14. The place of thrombolysis in the management of cerebral embolism after heart valve replacement.
    Wardlaw JM
    J Heart Valve Dis; 1994 Nov; 3(6):611-2. PubMed ID: 8000603
    [No Abstract]   [Full Text] [Related]  

  • 15. [GISSI-2; the beginning of the end or the end of the beginning for tissue plasminogen activator in acute myocardial infarct?].
    Lubsen J
    Ned Tijdschr Geneeskd; 1990 May; 134(19):940-4. PubMed ID: 2112233
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thrombolytic therapy of ischemic heart disease].
    Kanmatsuse K; Nagao K; Kikushima K; Shioiri K
    Nihon Naika Gakkai Zasshi; 1997 Sep; 86(9):1625-8. PubMed ID: 9410972
    [No Abstract]   [Full Text] [Related]  

  • 17. Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries.
    Cox JL; Lee E; Langer A; Armstrong PW; Naylor CD
    CMAJ; 1997 Feb; 156(4):497-505. PubMed ID: 9054819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombolytic therapy in acute myocardial infarction. Mechanism of action and treatment considerations].
    Roguin A; Manaster J; Roguin N
    Harefuah; 1993 Jun; 124(12):770-5. PubMed ID: 8375772
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombolytic therapy for acute myocardial infarction. Are inclusion criteria too stringent?
    Handlin LR; Vacek JL
    Postgrad Med; 1994 Mar; 95(4):77-82. PubMed ID: 8121861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolytic therapy in acute myocardial infarction.
    Hampton JR
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():241-6. PubMed ID: 9211016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.